Resistance to fludarabine-induced apoptosis in Epstein-Barr virus infected B cells
- 27 June 2002
- journal article
- research article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 21 (29), 4473-4480
- https://doi.org/10.1038/sj.onc.1205554
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.This publication has 36 references indexed in Scilit:
- The role of STATs in transcriptional control and their impact on cellular functionOncogene, 2000
- MDM2 — master regulator of the p53 tumor suppressor proteinGene, 2000
- Interferon γ Induces the Expression of p21waf-1 and Arrests Macrophage Cell Cycle, Preventing Induction of ApoptosisImmunity, 1999
- BCL-2 FAMILY: Regulators of Cell DeathAnnual Review of Immunology, 1998
- The role of p53 in regulating genomic stability when DNA and RNA synthesis are inhibitedTrends in Biochemical Sciences, 1995
- p53 Status and the Efficacy of Cancer Therapy in VivoScience, 1994
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- FludarabineDrugs, 1993
- Induction of bcl-2 expression by epstein-barr virus latent membrane protein 1 protects infected B cells from programmed cell deathCell, 1991
- The Pathogenesis of Burkitt's LymphomaAdvances in Cancer Research, 1990